Presence of impurity N-Nitroso-propanolol above the acceptable concentration limit in affected lots.
Hazard description
Contamination
What to do
Contact your health care provider to discuss other treatment options, as there are no other companies marketing extended release propranolol in Canada. Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition poses a greater health risk. Contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries and at 1-800-387-4974 for general inquiries if you have questions about the recall. Report any health product-related side effects or complaints to Health Canada.
Product
Product name
Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths
Reference
ID
RA-63959
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker